Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030035/S211

Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps

ABBOTT MEDICAL · Decision date Jul 21, 2026

FDA DECISIONP030035/S211

What did the FDA approve?

FDA records P030035/S211 as a supplement to PMA P030035, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 21, 2026.

FDA approval order statement

approval for Merlin 2 Patient Care System (PCS) programmer support for the AVEIR Leadless Pacemakers.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Jul 21, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P030035/S211
Regulatory pathway
PMA supplement
Product code
NKE
Decision code
APPR
Decision date
Jul 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P).

Product code
NKE
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P030035/S211 received

    Application receipt date recorded by FDA.

  2. P030035/S212 · Related supplement

    Anthem, Allure/RF, Allure Quadra/RF family of CRT-Ps

  3. P030035/S211 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P030035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030035

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementApr 24, 2026FDA

Explore the linked device profile

Other records with product code NKE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
15900 Valley View Ct., Sylmar, CA, 91335

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records